)
)
Mendus Investor Relations Material
Latest events
Q4 2024
Mendus
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Mendus
Access all reports
Mendus AB, a biopharmaceutical company, develops immunotherapies and relapse vaccines for the treatment of cancer. The company's main focus is on the development of prophylactic and therapeutic dendritic cell vaccines based on ilixadencel for the treatment of different solid tumor types. It is also involved in the development of INTUVAX, an allogeneic tumor cell vaccine to be used following surgery and anti-cancer therapy in patients with colorectal cancer or hepatocellular carcinoma to prevent recurrences.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
IMMU
Country
🇸🇪 Sweden